VASO CORPORATION
VASO · Healthcare · $34.5M mkt cap · FY2025 filings · Shallow moat ·
On the watchlist
The four filters
Median gross margin 57.1% over 10y, very stable.
Median ROIC 7.7%, above the 9% hurdle in 44% of years.
Net debt/EBITDA n/ax, interest coverage -116x.
Owner earnings +3.9%/yr, share count growing (dilution).
Margin of safety
- Owner earnings (normalized)
- $4.8M
- Est. intrinsic value / share
- $0.30
- Recent price
- $0.20
- Discount to value
- 35% below value
Conservative model: 9% discount rate, 0% assumed growth (capped at 4%), maintenance capex ≈ min(capex, D&A).
Fundamentals
There's no normalized fundamentals series for VASO yet — it appears once ingest has processed its filings.
Moat Score history
Score history begins Jul 17, 2026 — the record builds from here and can’t be backfilled.
Tier changesSame-methodology crossings of the Wide / Narrow / Shallow bars
None yet — VASO has read Shallow moat for every logged capture since Jul 17, 2026.
Scores are logged append-only and never overwritten — this record can’t be backfilled, which is exactly why it’s worth keeping.
Healthcare context
#121 of 440 scored Healthcare companies, ranked by Moat Score.
Nearest peers by Moat Score
- #119IDXG INTERPACE BIOSCIENCES, INC.49.3 out of 100, Shallow moatShallow moat
- #120BIO Bio-Rad Laboratories, Inc.49.0 out of 100, Shallow moatShallow moat
- #122BMRN BioMarin Pharmaceutical Inc49.0 out of 100, Shallow moatShallow moat
- #123WHWK Whitehawk Therapeutics, Inc.49.0 out of 100, Shallow moatShallow moat
Compare VASO with its nearest peers →All Healthcare companies on the Index →
Common questions about VASO
- Does VASO CORPORATION have an economic moat?
- Based on its FY2025 SEC filings, the Moat Index scores VASO CORPORATION (VASO) 49.0 out of 100 — a Shallow moat. The four filters behind that score (each 0–100): pricing power 94, returns on capital 27, balance-sheet safety 28, capital discipline 36.
- Is VASO stock trading below its intrinsic value?
- Against a deliberately conservative owner-earnings model (9% discount rate, 0% assumed growth, capped at 4%), estimated intrinsic value is $0.30 per share versus a recent price of $0.20 — 35% below value. This is an educational estimate computed from primary SEC filings, not investment advice.
- How has VASO's Moat Score changed over time?
- The record logs 2 readings since Jul 17, 2026; the latest reads 49.0 out of 100 (shallow moat). No tier changes on record yet. The history is append-only — readings are only ever added, never rewritten.